Phonocure: Precision in Supportive Care
Harnessing phonon physics for scalable hospital pilot programs.
Rated 4.8/5
★★★★★
We translate advanced physics into data-driven vibroacoustic protocols designed for supportive care settings. Evaluation is structured under clinical governance with baseline and follow-up measurement to ensure statistical discipline without overstating outcomes.
Our Services
Precision vibroacoustic protocols designed for supportive care in clinical settings.
Clinic & Hospital Pilots
Complementary adjunct for post-op recovery/supportive care (pain/anxiety/fatigue in cardiac/surgical patients via non-invasive sound resonance.
Structured trials to evaluate impact on post-op comfort, relaxation, and sleep quality (QoL).
Protocol Design
Custom vibroacoustic patterns based on explorative physics pushing state of the art.
We blend cutting-edge physics with established sound therapy, delivering deeper, non-invasive resonance for wellbeing and symptom management.
In silico modeling indicate enhanced wave penetration and resonance.
Developed under clinical oversight to meet stringent supportive care technology standards to improve Quality of Life.
Statistically significant reductions in anxiety (~82% average from aligned meta-analyses), pain, and fatigue in vibroacoustic-supported settings
Training & Support
Subscribe Now
Stay updated on Phonocure’s latest developments
About Us
Phonocure pioneers supportive-care technology grounded in explorative physics and vibroacoustic therapy.
We blend cutting-edge physics with established sound therapy, delivering deeper, non-invasive resonance for wellbeing and symptom management.
Addressing Medically Unexplained Symptoms & Functional Somatic Disorders
Targeting the Overlooked Burden MUS / Functional Somatic Disorders. Persistent physical symptoms (e.g., chronic pain, fatigue, functional neurological issues) affect ~8–9% of Europeans, often without clear organic cause — leading to high healthcare costs and patient distress. Phonocure evolves vibroacoustic approaches (recent multimodal protocols show promise in FND, fibromyalgia, chronical fatigue, endometriosis and adenomyosis) with phonon physics for deeper resonance and natural symptom support. Potential adjunct for specialized FSD clinics, oncology supportive care, and integrative hospital programs in the Nordics and Europe.
High prevalence in Nordics (e.g., Norway ~17% overall functional disorders)
Growing demand for non-pharma options amid EU Beating Cancer Plan & mental health focus
Complementary to CBT/multimodal care
Projects
Current initiatives shaping Phonocure’s impact.
Clinic & Hospital Pilot
Collaborating with clinical partners to evaluate phonocure’s supportive-care protocols in post-operative recovery, focusing on comfort and relaxation outcomes under strict clinical governance.
Investor Opportunities & Path to Public Listing
Phonocure is primed for accelerated growth by advancing its proprietary novel acoustic technology, following completed proof-of-concept demonstrating statistically significant links in high volume data (checked for false significance from multiple testing) between symptoms/illnesses and targeted sound/frequencies.
Key milestones: Proof-of-concept complete, Phase 1/2 run-in pending approval by REK (Regional Ethics Committee), with hospital/clinic pilots targeted for launch in Nordics/Europe 2026 (subject to ethics and regulatory clearances).
We are actively exploring and pursuing opportunities for M&A into a suitable listed shell or alternative public pathway to access capital for scaling pilots, evidence generation, and commercialization in high-unmet-need areas (functional somatic disorders, oncology supportive care, and complementary therapy markets).
Outcomes: Hospital/clinic therapy rooms with sound beds/headphones, professional integrative care scenes. FND supportive care, Nordics integrative medicine.
Only company bridging advanced acoustic physics with validated vibroacoustic outcomes and rigorous statistical symptom-frequency correlations
High-margin recurring revenue model (pilots → protocol implementations → training/subscriptions)
Targeting €8–18M initial TAM in Nordics, with strong scaling potential Europe-wide in growing adjunct therapy space
Accredited investors: Early participation sought for pre-RTO alignment and strategic support
Early pilot alignments with hospital protocols show improved patient wellbeing and reduced symptom burden. Builds on FDA-registered vibroacoustic Class I devices and emerging FND/music therapy case series.
Get in Touch
Reach out to discuss with our team clinic or hospital pilots or patient attendancy.
P
+47 90 23 19 62
E
martin.hammersborg@phonocure.com